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Abstract Gamma-aminobutyric acid transaminase (GABA-
T) deficiency is an autosomal recessive disorder reported in
only three unrelated families. It is caused by mutations in the
ABAT gene, which encodes 4-aminobutyrate transaminase, an
enzyme of GABA catabolism and mitochondrial nucleoside
salvage. We report the case of a boy, deceased at 12 months of
age, with early-onset epileptic encephalopathy, severe psycho-
motor retardation, hypotonia, lower-limb hyporeflexia, central
hypoventilation, and rapid increase in weight and, to a lesser
rate, length and head circumference. He presented signs of
premature pubarche, thermal instability, and water–electrolyte
imbalance. Serum total testosterone was elevated (43.3 ng/dl;
normal range <16), as well as serum growth hormone
(7.7 ng/ml; normal range <1). Brain magnetic resonance im-
aging (MRI) showed decreased myelination and generalized
brain atrophy, later confirmed by post-mortem examination.
ABAT gene sequencing was performed post-mortem, identify-
ing a homozygous variant c.888G > T (p.Gln296His),not pre-
viously described. In vitro analysis concluded that this variant
is pathogenic. The clinical features of this patient are similar to
those reported so far in GABA-T deficiency. However, dis-
tinct mutations may have a different effect on enzymatic
activity, which potentially could lead to a variable clinical
outcome. Clinical investigation aiming for a diagnosis should
not end with the patient’s death, as it may allow a more precise
genetic counselling for the family.
Fig. 1 Patient’s photos (note the increasingly Bpuffy^ appearance) at
2 months (a), 5 months (b), 10 months (c), and 11 months (d) of age
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Fig. 2 Patient’s weight (a),
length (b), and head
circumference growth (c) (growth
charts reproduced with
permission from World Health
Organization)
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Introduction
Gamma-aminobutyric acid transaminase (GABA-T) deficien-
cy (MIM#613163) is an autosomal recessive disorder reported
in only three unrelated families (Jaeken et al 1984; Tsuji et al
2010; Besse et al 2015). It is caused by mutations in the ABAT
gene (HGNC_ID:23), which encodes 4-aminobutyrate trans-
aminase (EC 2.6.1.19), an enzyme of GABA catabolism and
mitochondrial nucleoside salvage (Besse et al 2015). GABA-
T deficiency is usually characterized by elevated levels of
GABA in cerebrospinal fluid (CSF), associated with severe
psychomotor retardation, intractable seizures, hypotonia with
hyperreflexia, accelerated height growth, and a high-pitched
cry (Jaeken et al 1984; Tsuji et al 2010; Besse et al 2015).
Case report
The patient (Fig. 1) was a Portuguese male infant, born full
term by caesarean delivery due to cephalopelvic dispropor-
tion. He was the first child of healthy parents. Consanguinity
was denied but both parents originate from the same
Portuguese region. He was admitted at the age of 3 days for
generalized hypotonia since birth, progressing to encephalop-
athy and coma. Electroencephalography (EEG) showed a
burst-suppression pattern compatible with early-onset epilep-
tic encephalopathy. Levetiracetam was started, initially reduc-
ing the frequency of seizures, but ultimately with no effect.
Until his death at the age of 12 months, he presented severe
psychomotor retardation, lower-limb hyporeflexia, central
hypoventilation, bilateral cryptorchidism, and a rapid increase
in weight, as well as in length and head circumference, al-
though to a lesser rate (Fig. 2). He had a general “puffy”
appearance, signs of premature pubarche, thermal instability,
and water–electrolyte imbalance. He needed noninvasive ven-
tilation and tube feeding.
Serum total testosterone was elevated (43.3 ng/dl; normal
range <16), as was serum growth hormone (7.7 ng/ml; normal
range <1). Brain magnetic resonance imaging (MRI) showed
decreased myelination and generalized cerebral, cerebellar,
and brainstem atrophy, later confirmed by post-mortem exam-
ination. Diffusion-weighted images revealed bilateral hyper-
intense areas involving subcortical and periventricular white
matter, and globus pallidus (Fig. 3). Magnetic resonance spec-
troscopy (MRS) showed no abnormalities. Neuropathological
examination revealed soft consistency of the white matter.
Microscopically, subcortical white matter is seen as a pale-
stained/poorly myelinated area on the slide (Fig. 4).
The diagnosis of GABA-T deficiencywas considered post-
mortem. ABAT gene sequencing identified a homozygous var-
iant c.888G > T (p.Gln296His), previously undescribed.
MutationTaster, PolyPhen2 and SIFT predict this variant to
be, respectively, “disease causing”, “probably damaging”
and “damaging”. In vitro analysis concluded that this variant
is pathogenic (Pop et al 2015). At the time of the diagnosis, the
patient’s parents had an 11-weeks’ gestation. Chorionic villus
sampling was performed, and molecular analysis confirmed
that the fetus was not homozygous for the pathogenic variant.
Discussion
The clinical features of this patient are similar to those report-
ed in GABA-T deficiency cases (Table 1). Interestingly,
Fig. 3 Brain magnetic resonance imaging (MRI) at 12 months of age.
Diffusion-weighted axial images show bilateral hyperintense areas
involving subcortical and periventricular white matter, and globus
pallidus
Fig. 4 Cerebral cortex and poorly myelinated subcortical white matter
(Paraffin section, Klüver-Barrera staining, ×40) (a). Poorly myelinated
subcortical white matter (Paraffin section, Klüver-Barrera staining,
×200) (b)
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hyperreflexia was not present in our patient. His weight gain
almost overshadowed length growth. These growth alterations
seem to be related with the abnormally high levels of growth
hormone, while the signs of premature pubarche are likely to
be related with the high testosterone levels, which may also
have contributed to the patient’s “puffy” appearance. High
GABA levels probably contributed to this hormone imbalance
(Jaeken et al 1990; Ritta et al 1998).
Certain mutations express a residual enzymatic activity
(Pop et al 2015), which potentially could lead to a variable
clinical outcome. However, other (epi)genetic factors could
also have an effect. CSF amino acid analysis was performed
but did not include free GABAmeasurement; when GABA-T
deficiency was considered, it could not be performed due to
the lack of a CSF sample. This reinforces the need for the
rigorous implementation of sample collection and storing pro-
tocols, mostly in severely affected patients, during life and
even at post-mortem. However, lumbar puncture is an inva-
sive procedure, and sampling is not always easy. In our case,
collected CSF volume was not enough to store.
Detection of brain GABA elevation by MRS is difficult
and usually requires a technical modification (Levy and
Degnan 2013), which was not considered in this patient while
he was alive. GABA-T is also involved in the mitochondrial
nucleoside salvage pathway. Mitochondrial DNA (mtDNA)
copy number measurement was not performed in our case,
but an mtDNA depletion was previously demonstrated in fi-
broblasts from other patients (Besse et al. 2015). Evidence of a
depletion would probably have misled us to disorders with
phenotypic overlap, such as the mtDNA depletion syndromes
caused by mutations in SUCLG1 and SUCLA2 genes (Besse
et al 2015). Clinical investigation aiming a diagnosis should
not end with the patient’s death, as it may allow a more precise
genetic counselling for the families. In our case, it allowed us
to offer our patient’s parents a molecular prenatal diagnosis.
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